STOCK TITAN

Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Harvard Bioscience, Inc. (HBIO) will release its financial results for Q4 2023 on March 7, 2024. A conference call will be held at 8:00 a.m. Eastern Time for discussion. Participants can register to join the call and access the webcast for more details.
Positive
  • None.
Negative
  • None.

HOLLISTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2023 before the market opens on March 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.

Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.

Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here.

Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website.

About Harvard Bioscience 

Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in the United States, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.
For more information, please visit our website at www.harvardbioscience.com.

Investor Inquiries:
Harvard Bioscience, Inc.
Investor Relations
investors@harvardbioscience.com
(508) 893-3120


FAQ

When will Harvard Bioscience release its financial results for Q4 2023?

Harvard Bioscience will release its financial results for the quarter ended December 31, 2023, on March 7, 2024.

What time will the conference call to discuss the financial results be held?

The conference call to discuss the financial results will be held at 8:00 a.m. Eastern Time.

How can participants join the conference call?

Participants who would like to join the call and ask a question must register on the provided link. Once registered, they will receive the dial-in numbers and a unique PIN number.

Where can participants access the audio-only webcast?

Participants who would like to join the audio-only webcast should go to the events and presentations section on the investor website.

Where will the financial information be available?

Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website.

Harvard Bioscience Inc

NASDAQ:HBIO

HBIO Rankings

HBIO Latest News

HBIO Stock Data

92.25M
40.23M
7.77%
76.04%
0.86%
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States of America
HOLLISTON